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Abstract. Pseudo-spectral approximations are constructed for the model equa-
tions which describe the population kinetics of human tumor cells in vitro and
their responses to radiotherapy or chemotherapy. These approximations are
more efficient than finite-difference approximations. The spectral accuracy of
the pseudo-spectral method allows us to resolve the model with a much smaller
number of spatial grid-points than required for the finite-difference method to
achieve comparable accuracy. This is demonstrated by numerical experiments
which show a good agreement between predicted and experimental data.
1. Introduction. Patient responses, and in some cases non-responses, to cancer
therapies such as radiation, chemotherapy and combination treatments are not com-
pletely understood. In vitro studies have shown that therapies may target the cellu-
lar mechanisms of growth, division and death in all or some stages of the cell cycle
[1]. Even in the simplified environment of the laboratory with modern techniques it
is not always possible to isolate the effects of cancer treatment on the cell cycle of
human cancer cell lines yet this is crucial if we are to understand drug mechanisms
and patient responses to therapy.
With this in mind a mathematical model for the kinetics of a population of
cells differentiated by phases of the cell division cycle and length of time within
each phase has been developed and used to describe the effects of a number of
cancer therapies in vitro ([2, 3, 4, 5, 6, 11, 7]). Validation of the model is achieved
by comparing model and data flow cytometric profiles of human melanoma cell
lines. Model parameters that cannot be determined experimentally are chosen to
optimally fit model and data.
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Flow cytometry is a technique where the DNA content of individual cells is mea-
sured and binned accordingly. The resulting histogram is termed a ‘flow cytometric
profile’ and for cells unperturbed by therapy consists of two distinct peaks (Fig. 1)
one with double the DNA content of the other. The tallest peak is the cluster of
cells in the first phase of the cell cycle. The second peak, at double the DNA content
of the first consists of cells that are nearing the end of the cell cycle and are about
to divide. Perturbation by cancer therapy causes these peaks to change in relation
to one another (Fig. 2). A mathematical model is the ideal tool for analysing flow
cytometric profiles and isolating the underlying drug mechanisms.
Because optimisation routines require numerous model iterations, further appli-
cations of the model would be enhanced by finding an efficient numerical algorithm
to solve the model. In this paper we summarize the model, then we apply both finite
difference and pseudo-spectral methods for the numerical solution of the model. We
conclude that, for the equations describing the population kinetics of human cancer
cells in vitro, the pseudo-spectral method is more efficient than the finite difference
method. Moreover, the difference in efficiency of both methods increases with in-
creasing length of the time interval (domain of the time variable used in the model).
This conclusion suggests the choice of the pseudo-spectral method for the estima-
tion of the optimal parameter values which have to be found for the mathematical
model.
The organization of this paper is as follows. In Section 2, we provide a mathemat-
ical description of the model equations. The processes of the spatial discretization of
the model by the finite-difference and pseudo-spectral methods are then described
in Sections 3 and 4, respectively. The numerical experiments with the model are
presented in Section 5. Finally, in Section 6 some concluding remarks are given.
2. Mathematical model. The cancer cell division cycle can be divided into four
distinct phases, namely the G1-phase, DNA synthesis or S-phase, G2-phase, and
mitosis or M -phase; see Fig. 1 of [2], which expresses the accumulation of cells in
each of the phases and the movement of cells between them. The transitions between
the G1, S, G2, M -phases are controlled by stochastic processes. The mathematical
model, which was developed in [2], describes these phases and the transition rates
between them, and is based on the system of partial differential equations of the
form 

∂G1(x, t)
∂t
= 4bM(2x, t) − (k1 + µG1)G1(x, t),
∂S(x, t)
∂t
= ε
∂2S(x, t)
∂x2
− µS S(x, t) − g
∂S(x, t)
∂x
,
+ k1 G1(x, t) − I(x, t;TS),
∂G2(x, t)
∂t
= I(x, t;TS) − (k2 + µG2)G2(x, t),
∂M(x, t)
∂t
= k2 G2(x, t) − bM(x, t) − µM M(x, t).
(2.1)
Here, t ≥ 0 is time (measured in hours) and x is the dimensionless relative DNA
content. The dependent variables, G1(x, t), S(x, t), G2(x, t) and M(x, t) represent
the density of cells in the corresponding phases. The delay term I(x, t;TS) repre-
sents cells that have been in S-phase for TS hours and are ready to be transferred
to G2-phase. The derivation of this term is explained in detail in [2]. In short
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I(x, t;TS) is the solution of the diffusion equation
∂I(x, t; τS)
∂τS
+ g
∂I(x, t; τS)
∂x
− ε∂
2I(x, t; τS)
∂x2
+µS I(x, t; τS) = 0, 0 < x <∞, t > τS > 0,
at time τS = TS where τS is the time since arrival in S-phase. The analytical
solution (with appropriate initial conditions and a zero flux boundary condition) is
obtained using Laplace transform techniques and Green’s functions. Thus I(x, t;TS)
is given by

I(x, t;TS) =
∫
∞
0
k1 G1(y, t− TS) γ(TS , x, y)dy, t ≥ TS,
I(x, t;TS) = 0, t < TS,
(2.2)
where γ(τ, x, y) is a weight function given by
γ(τ, x, y) =
exp(−µSτ)
2
√
piετ
(
exp
(
−
(
(x− gτ)− y
)2
4ετ
)
−
(
1 + ν(τ, x, y)
)
exp
(
−
(
x+ gτ) + y
)2
4ετ
)) (2.3)
with
ν(τ, x, y) =
x+ y
gτ
(
1 +O(τ−1
)
.
Here γ is a Greens function and the ν term arises due to the zero flux boundary
condition.
The parameters µG1 , µS , µG2 , and µM are the death rates in G1, S, G2, and
M -phases, respectively. The parameters k1 and k2 are the transition probabilities
of cells from G1 to S-phase and from G2 to M -phase, respectively; b is the division
rate; ε is the dispersion coefficient; and g is the average growth rate of DNA in
the S-phase. The 4bM(2x, t) term on the right hand side of the first equation
in (2.1) arises due to a change of variable in the derivation as cells in an interval
[2x, 2x + 2∆x] are doubled in number and transferred to the interval [x, x + ∆x]
with half the DNA content.
In this paper, we consider constant parameters, like in [2], but in general, they
all may be functions of either x or t, or both of these variables.
The system (2.1) is incomplete and should be supplemented with initial and
boundary conditions. These side conditions, which are chosen according to experi-
mental evidence, take the form

G1(x, 0) =
a0√
2piθ20
exp
(
− (x− 1)
2
2θ20
)
, 0 < x <∞,
S(x, 0) = 0, G2(x, 0) = 0, M(x, 0) = 0, 0 < x <∞,
(2.4)
and
ε
∂S(0, t)
∂x
− g S(0, t) = 0, t > 0. (2.5)
Here, the initial DNA content of cells in the G1-phase is chosen as a Gaussian
distribution with relative mean DNA content at x = 1 equal to a0, and variance θ
2
0 .
This variance is chosen sufficiently small so that the extension of G1(x, 0) into the
infeasible region x < 0 is of no significance.
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In Sections 3 and 4 we construct numerical solutions to (2.1) supplemented by
the initial condition (2.4) and the general boundary conditions of the form
 ε
∂S(0, t)
∂x
− g S(0, t) = α, t > 0,
S(L, t) = β, t > 0,
(2.6)
with any real values α and β. The case α = 0 corresponds to the zero flux condition
(2.5). The parameter β can be chosen according to the experimental data provided
in [2]. In Section 3 we investigate the finite-difference method while in Section
4 we investigate the pseudo-spectral method for the model equations (2.1). The
pseudo-spectral method demonstrates better efficiency for the model (2.1) than the
finite-difference method. This is illustrated by the results of numerical experiments
presented in Section 5. Finally, in Section 6, some concluding remarks are given
and plans for future research are briefly outlined.
3. Finite difference spatial discretization of the model. In this section we
discretize the equation for S in (2.1) in space by the finite-difference method. For
a given positive integer N let ∆x = L/N and define the uniform grid
xi = (i− 1)∆x, i = 1, 2, . . . , N + 1.
Our choice of the finite-difference operator for the first order derivative ∂S/∂x in the
advection-diffusion equation for the S-phase in (2.1) is dictated by the parameter
values ε and g. Since the practical values of the parameter ε are arbitrarily close
to zero and the practical values of the parameter g are isolated from zero, the so-
called cell Peclet number g∆x/ε is arbitrarily large. In this case the equation for S
in (2.1) is advection-dominated and use of the second order central finite-difference
operator for the first order derivative ∂S/∂x may lead to numerical oscillations if
∆x is not depressed to very small values which lead to very expensive numerical
solutions, see [9]. Therefore, for the first order spatial derivative in (2.1) we apply
the approximations
∂S(xi, t)
∂x
≈ S(xi, t)− S(xi−1, t)
∆x
, (3.1)
for i = 2, 3, . . . , N . For i = 1 we apply the Neumann boundary condition in (2.6),
which gives the exact value for the derivative at x1 = 0
∂S(x1, t)
∂x
=
g S(x1, t) + α
ε
. (3.2)
For the second order spatial derivative we apply the approximations
∂2S(xi, t)
∂x2
≈ S(xi−1, t)− 2S(xi, t) + S(xi+1, t)
∆x2
, (3.3)
i = 2, 3, . . . , N . For i = 1 we apply again the Neumann boundary condition in (2.6),
which results in
∂2S(x1, t)
∂x2
≈ 1
∆x
(
S(x2, t)− S(x1, t)
∆x
− g S(x1, t) + α
ε
)
. (3.4)
The Dirichlet condition in (2.6) gives
S(xN+1, t) = β. (3.5)
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Put
S(t) =


S(x1, t)
S(x2, t)
...
S(xN , t)

 , dS(t)dt =


∂S
∂t
(x1, t)
∂S
∂t
(x2, t)
...
∂S
∂t
(xN , t)


,
r(t;TS) =


k1G1(x1, t)− I(x1, t;TS)
k1G1(x2, t)− I(x2, t;TS)
...
k1G1(xN , t)− I(xN , t;TS)

 , v =


α
(
2
∆x
+
g
ε
)
0
...
0

 ,
and
A =


aˆ 2c 0 . . . . . . 0
bˆ a c
. . .
...
0 bˆ a c
. . .
...
...
. . .
. . .
. . .
. . . 0
...
. . . bˆ a c
0 . . . . . . 0 bˆ a


,
with
a = − 2ε
∆x2
− g
∆x
, aˆ = − 2ε
∆x2
− 2g
∆x
− g
2
ε
, bˆ =
ε
∆x2
+
g
∆x
, c =
ε
∆x2
.
Applying the approximations (3.1)-(3.4) to the equation for S in (2.1) results in the
system of ordinary delay differential equations
dS(t)
dt
= AS(t)− µSS(t) + r(t;TS)− v, (3.6)
with the length TS of the delay.
Since the right-hand sides of the equations for G1, G2 and M in (2.1) do not
include partial derivatives in x, the semi-discrete equations for these variables take
the following form

dG1(t)
dt
= 4bM (2)(t) − (k1 + µG1)G1(t),
dG2(t)
dt
= I(t;TS) − (k2 + µG2)G2(t),
dM(t)
dt
= k2 G2(t) − bM(t) − µM M(t).
(3.7)
Here,
Gj(t) =


Gj(x1, t)
Gj(x2, t)
...
Gj(xN+1, t)

 , j = 1, 2, I(t;TS) =


I(x1, t;TS)
I(x2, t;TS)
...
I(xN+1, t;TS)

 ,
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M(t) =


M(x1, t)
M(x2, t)
...
M(xN+1, t)

 , M (2)(t) =


M
(2)
1 (t)
M
(2)
2 (t)
...
M
(2)
N+1(t)

 ,
where the values M
(2)
i (t) are defined by
M
(2)
i (t) =
{
M(2xi, t) if 2xi ≤ L,
0 if 2xi > L,
according to the experimental data provided in [2].
The system of equations (3.6)-(3.7) create a finite-difference semi-discrete ap-
proximation for the whole model (2.1). The results of numerical experiments with
(3.6)-(3.7) are presented in Section 5.
4. Pseudo-spectral spatial discretization of the model. In this section, to
compute numerical approximations to the S-phase, we discretize the corresponding
parabolic equation in (2.1) with respect to x by pseudo-spectral method based on
the Chebyshev-Gauss-Lobatto points
xi =
L
2
(
1− cos (i− 1)pi
N
)
,
for i = 1, 2, . . . , N + 1, on the interval [0, L].
The first order spatial derivative which appears in the equation for S in (2.1) can
be replaced by the spectrally accurate approximations at the spatial grid-points xi
∂S(xi, t)
∂x
≈
N∑
j=1
dijS(xj , t) + βdi,N+1, (4.1)
for i = 2, 3, . . . , N + 1, where we incorporated the Dirichlet boundary condition
(3.5). Here,
D(1) =
[
dij
]N+1
i,j=1
is the differentiation matrix of the first order (see [8] and [12]). For i = 1 the first
condition in (2.6) leads to
∂S(x1, t)
∂x
=
g S(x1, t) + α
ε
(4.2)
as in the case of finite-difference approximation. The relations (4.1)-(4.2) result in
the approximation
Sx(t) ≈ D0S(t) + βd(0)N+1 + b1e1 (4.3)
with the following notations
D0 =


0 0 . . . 0
d21 d22 . . . d2,N
...
...
. . .
...
dN,1 dN,2 . . . dN,N

 , e1 =


1
0
...
0

 ,
IN VITRO HUMAN TUMOR CELL POPULATION KINETICS 7
Sx(t) =


∂S(x1, t)
∂x
∂S(x2, t)
∂x
...
∂S(xN , t)
∂x


, d
(0)
N+1 =


0
d2,N+1
...
dN,N+1

 ,
and
b1 =
g S(x1, t) + α
ε
.
The second order spatial derivative which appears in the equation for S in (2.1) can
also be replaced by spectrally accurate approximations at the spatial grid-points xi.
These approximations are written in the form
∂2S(xi, t)
∂x2
≈ b1di1 +
N+1∑
j=2
dij
∂S(xj , t)
∂x
, (4.4)
for i = 1, 2, . . . , N . The relations (4.4), (4.3) and (4.1) result in the approximation
Sxx(t) ≈ DSx(t) +
(
N∑
j=1
dN+1,jS(xj , t) + dN+1,N+1β
)
dN+1
≈ D
(
D0S(t) + βd
(0)
N+1 + b1e1
)
+
(
N∑
j=1
dN+1,jS(xj , t) + dN+1,N+1β
)
dN+1,
(4.5)
with the notations
Sxx(t) =


∂2S(x1, t)
∂x2
∂2S(x2, t)
∂x2
...
∂2S(xN , t)
∂x2


, dN+1 =


d1,N+1
d2,N+1
...
dN,N+1

 ,
and
D = D(1)(1 : N, 1 : N) =


d11 d12 . . . d1,N
d21 d22 . . . d2,N
...
...
. . .
...
dN,1 dN,2 . . . dN,N

 .
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The approximations (4.3) and (4.5) applied to the partial differential equation for
S in (2.1) result in the following system of ordinary delay differential equations
dS(t)
dt
= ε
(
D
(
D0S(t) + βd
(0)
N+1 + b1e1
)
+
( N∑
j=1
dN+1,jS(xj , t) + dN+1,N+1β
)
dN+1
)
− µS S(t)
− g
(
D0S(t) + βd
(0)
N+1 + b1e1
)
+ r(t;TS).
(4.6)
with the length TS of the delay.
As in Section 3 the system of equations (4.6) is supplemented with the system
(3.7) which corresponds now to the Chebyshev-Gauss-Lobatto points xi defined at
the beginning of this section. This leads to the overall pseudo-spectral semi-discrete
approximation for the whole model (2.1). The results of numerical experiments with
this approximation (4.6), (3.7) are then presented in Section 5 and compared with
experimental data.
5. Numerical experiments. In the previous two sections we described the algo-
rithms for the discretization in space of the model equations (2.1)-(2.2). In Section 3
the equation for the variable S(x, t) was discretized by finite-difference approxima-
tions (3.1)-(3.4) and in Section 4 by pseudo-spectral approximations (4.3) and (4.5).
This leads to the overall systems of delay-differential equations (DDEs) (3.6)-(3.7)
or (4.6)-(3.7), respectively. Here, the delay TS enters the equations for S(x, t) and
G2(x, t) through the terms r(t;TS) with I(x, t;TS) defined by (2.2). The numerical
solution of models similar to (2.1)-(2.2) by finite-difference methods is also briefly
discussed in [6].
To solve the resulting systems of DDEs we first describe the algorithm for
(3.7). This algorithm is based on backward differentiation method of the first order
(BDF1) to compute the necessary starting values, followed by the backward differ-
entiation method of order p = 3 on the remainder of the interval of integration,
applied to the system (3.7) reordered as follows

dG2(t)
dt
= I(t;TS) − (k2 + µG2)G2(t),
dM(t)
dt
= k2 G2(t) − bM(t) − µM M(t),
dG1(t)
dt
= 4bM (2)(t) − (k1 + µG1)G1(t).
(5.1)
Then the algorithm based on BDF1 formula takes the form

G2,n+1 =
(
1 + ∆t
(
k2 + µG2
))−1(
G2,n +∆tIn+1−j
)
,
Mn+1 =
(
1 + ∆t
(
b + µM
))−1(
Mn + k2∆tG2,n+1
)
,
G1,n+1 =
(
1 + ∆t
(
k1 + µG1
))−1(
G1,n + 4b∆tM
(2)
n+1
)
,
(5.2)
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for n = 0, 1, . . . , nend. The algorithm based on BDF3 is the following

G2,n+1 =
(
11 + 6∆t
(
k2 + µG2
))−1(
Rn(G2) + 6∆tIn+1−j
)
,
Mn+1 =
(
11 + 6∆t
(
b+ µM
))−1(
Rn(M) + 6k2∆tG2,n+1
)
,
G1,n+1 =
(
11 + 6∆t
(
k1 + µG1
))−1(
Rn(G1) + 24b∆tM
(2)
n+1
)
,
(5.3)
with
Rn(f) = 18fn − 9fn−1 + 2fn−2, n = 2, 3, . . . , nend.
Here, nend is the integer such that nend∆t = tend, where tend is the end of the time
interval over which the system (3.7) has to be solved, and the vectors G2,n, In−j ,
Mn, M
(2)
n , and G1,n are approximations to G2(n∆t), I((n−j)∆t;TS), Mn(n∆t),
M
(2)
n (n∆t), andG1(n∆t), respectively. The approximations In−j to I((n−j)∆t;TS)
are computed using the formula (2.2), where the approximations to G1(y, (n−j)∆t)
are computed either from the initial condition (2.4) if (n − j)∆t = 0 or from the
previous stages of computations if (n− j)∆t > 0. The positive integer j is chosen
in such a way that
j∆t ≤ TS < (j + 1)∆t.
To approximate the integral in (2.2) which is defined over the infinite interval (0,∞)
we use the property that the kernel function γ(TS , x, y) defined by (2.3) is negligible
for all x ∈ [0, L] and y > L. This leads to the approximation

I(x, t;TS) ≈
∫ L
0
k1 G1(y, t− TS) γ(TS , x, y)dy, t ≥ TS,
I(x, t;TS) = 0, t < TS.
(5.4)
The integral in (5.4) is then approximated by the composite trapezoidal rule defined
on the uniform grid on the interval [0, L].
Experimental data Predicted data
0 0.5 1 1.5 2 2.5
0
50
100
150
200
250
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350
400
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Figure 1. Cell count versus DNA content for an unperturbed cell
line experimental (left) and predicted (right) data. The latter is
G1(x, t) + S(x, t) +G2(x, t) +M(x, t) at time t = 12.
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Experimental data Predicted data
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Figure 2. Cell count versus DNA content for a cell line perturbed
by the anti-cancer drug Taxol which inhibits cell division. Exper-
imental (left) versus predicted (right) data with the latter being
G1(x, t) + S(x, t) +G2(x, t) +M(x, t) at time t = 72.
Observe that the algorithm defined by (5.2) based on the BDF1 formula as well as
the algorithm defined by (5.3) based on the BDF3 formula are explicit since all the
values on the right hand sides of the corresponding equations are already known
from previous stages of the computations. This means that although BDF1 and
BDF3 are implicit methods, the algorithms (5.2) and (5.3) are explicit. Moreover,
the stability advantages of BDF methods, which are expensive because of their
impliciteness, are in this case for free if (5.2) and (5.3) are applied.
The remaining systems (3.6) or (4.6) resulting from semi-discretization in space
of the variable S(x, t) by finite-difference or pseudo-spectral methods, are then
solved by the code ode15s from the Matlab ODE suite [10]. In this process the
required terms r(n∆t;TS) are approximated using the values G1,n and In−j , n =
0, 1, . . . , nend, already computed by the algorithm described above for the numerical
solution of (5.1).
The results of our numerical experiments are presented in Fig. 1 and Fig. 2 and
compared with experimental data from [2]. In Fig. 1 we have the flow cytometric
profile of a human cell line unperturbed by cancer therapy. In Fig. 1 the cell line
has been perturbed by the anti-cancer trug Taxol which inhibits cell division and
causes cells to build up in the G2/M phase of the cell cycle.
The system (3.7) is solved by BDF3 with ∆t = 10−2 with starting values obtained
using BDF1 formula. The system (3.6) was solved by the code ode15s with N =
500, AbsTol = 10−5 and RelTol = 10−1 for tend = 12 and tend = 72 and the
numerical solutions are plotted by solid lines. For tend = 12 there are 76 successful
steps, 2 rejected steps, 599 function evaluations, 19 LU decompositions, and 97
solutions of linear systems. The time of integration is 12.24 sec. For tend = 72
there are 92 successful steps, 0 rejected steps, 605 function evaluations, 11 LU
decompositions, and 103 solutions of linear systems. The time of integration is
32.46 sec. The system (4.6) was solved by ode15s with N = 80, AbsTol = 10−5
andRelTol = 10−1 for the same values of tend = 12 and tend = 72 and the numerical
solutions are displayed as the symbols ‘⋄’. For tend = 12 there are 129 successful
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steps, 2 rejected steps, 381 function evaluations, 21 LU decompositions, and 155
solutions of linear systems. The time of integration is 3.48 sec, which is more than
three times faster than the time of integration by the finite-difference method. For
tend = 72 there are 99 successful steps, 4 rejected steps, 400 function evaluations,
17 LU decompositions, and 155 solutions of linear systems. The time of integration
is 7.52 sec, which is more than four times faster than the time of integration by the
finite-difference method.
The pseudo-spectral method is more efficient than the method based on the finite-
difference approach in spite of the fact that the pseudo-spectral method requires
more steps and more function evaluations. This can be explained by the fact that
the systems (4.6) have much smaller dimensions to achieve comparable accuracy
and as the result these function evaluations are much less expensive for pseudo-
spectral approach. Moreover, this difference in efficiency of pseudo-spectral methods
as compared with finite-difference approximations increases as the length of the
interval of integration increases.
6. Discussion. A new algorithm has been designed for a system of delay partial dif-
ferential equations. The algorithm is based on pseudospectral approximations and
has been investigated for the model equations (2.1)-(2.2) which describe the growth
of human tumor cells and their responses to radiotherapy or chemotherapy. It has
been demonstrated that the new algorithm for the numerical solution of (2.1)-(2.2)
is more efficient than the standard algorithm based on the finite-difference approxi-
mations. The pseudo-spectral method requires much smaller number of grid-points
than that needed for finite-difference method to reach comparable accuracy, and as
a consequence the resulting pseudo-spectral semi-discrete systems are much smaller
than the systems corresponding to finite-difference approximations. Discretization
in time of the smaller pseudo-spectral systems is more robust and more efficient
than discretization in time of the finite-difference systems. For the model equa-
tions integrated in time over the interval [0, 12], the pseudo-spectral method is
about three times more efficient than the finite-difference method and over the in-
terval [0, 72], the pseudo-spectral method is about four times more efficient than
the finite-difference method. The difference in efficiency of these methods increases
with increasing length of the time interval.
Our future work will address efficient numerical methods for estimating the pa-
rameter values of the model equations (2.1)-(2.2). These parameters have to be
computed iteratively by minimizing the error between the numerical solution to
(2.1)-(2.2) and the experimental data. Since this process usually has to be repeated
several times the design of efficient numerical algorithms for (2.1)-(2.2) is very im-
portant. Therefore, we will adopt the pseudo-spectral algorithm to compare the
numerical solutions with the experimental data. In order to obtain approximations
to the model solutions as close as possible to the experimental data we will inves-
tigate the model equations for the parameters k1, k2, ε, g, b, µG1 , µS , µG2 , and
µM belonging to different ranges. The numerical solutions computed for different
sets of the parameters will be used to minimize the sum of squared errors on the
appropriate grid. Since the pseudo-spectral algorithm is based on small numbers of
grid-points, it will save the computational time for each solution computed for one
set of the parameters.
Acknowledgements. With kind permission of Springer Science and Business Me-
dia, the two left-hand side pictures with experimental data in Fig. 1 and Fig. 2,
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with our numerical data. We would like to thank Springer Science and Business
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readers.
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